The FY2025 (Dec) proxy of BeOne Medicines names 13 peer companies for pay. Pay versus performance data of BeOne Medicines for that year is not on file, so it has no rank.
Pay peer group, FY2025 (Dec) proxy
| Exelixis | ||
| Incyte | ||
| Gilead Sciences | ||
| Biomarin Pharmaceutical | ||
| Moderna | ||
| United Therapeutics | ||
| Alnylam Pharmaceuticals | ||
| Regeneron Pharmaceuticals | ||
| Neurocrine Biosciences | ||
| Biogen | Not disclosed | Not disclosed |
| Jazz Pharmaceuticals | Not disclosed | Not disclosed |
| Sarepta Therapeutics, Inc. | Not disclosed | Not disclosed |
| Vertex Pharmaceuticals Inc. | Not disclosed | Not disclosed |
13 companies
Changes by year
FY2023 (Dec) proxy
- AddedUnited Therapeuticspay peer groupThe peer group used for 2023 pay decisions reflects the removal of Alexion Pharmaceuticals, Inc. (acquired) and Ionis Pharmaceuticals, Inc. (outside of size parameters), and the addition of United Therapeutics Corporation
- RemovedAlexion Pharmaceuticals, Inc.pay peer groupThe peer group used for 2023 pay decisions reflects the removal of Alexion Pharmaceuticals, Inc. (acquired) and Ionis Pharmaceuticals, Inc. (outside of size parameters), and the addition of United Therapeutics Corporation
- RemovedIonis Pharmaceuticalspay peer groupThe peer group used for 2023 pay decisions reflects the removal of Alexion Pharmaceuticals, Inc. (acquired) and Ionis Pharmaceuticals, Inc. (outside of size parameters), and the addition of United Therapeutics Corporation
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.